Dr. Susan Ya Ming Chon, MD

Dr. Chon practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Chon's NPI, 1336173285, was assigned on July 10, 2006. Dr. Chon graduated from Stanford University School Of Medicine in 1997. Dr. Chon holds Texas license L9142.

Dr. Chon's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Chon's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dr. Chon is also affiliated with Houston Methodist Hospital. The medical group on file is UT Physicians. Dmand AI also links Dr. Chon to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chon practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Chon's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Chon is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Chon's licenses on file in 6 states: Texas, California, Florida, Oklahoma, New York and Georgia.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Dr. Chon treats.

CMS data shows 2,036 Medicare services from Dr. Chon across 11 procedure codes in 2024, for 524 Medicare patients. Medicare paid $52,470 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 524 Medicare patients who saw Dr. Chon in 2024. The largest group is 65 to 74, with 262 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chon's median patient age at 72, with 57% women.

In 2024, Dr. Chon wrote 582 Medicare Part D claims for 248 patients. 95% of them were for generic drugs. CMS names the drug for 484 of them, across 15 drugs with 11 or more claims each, at $17,576 in total drug cost. In 2023, CMS named 428 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Chon for performance year 2024, reported as part of a group. Dr. Chon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 518 procedures of removal of skin lesions by Dr. Chon, more than 87% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 33 papers to Dr. Chon, published from 2007 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Antineoplastic Agents, Drug Eruptions and Skin Neoplasms. Dr. Chon has published most often in J Drugs Dermatol. Dr. Chon's most frequent co-authors are Victor G. Prieto, MD, PhD, Rashid M. Rashid, MD, PhD and Auris Onn-Lay Huen, MD.

CMS Open Payments shows 3 general payments to Dr. Chon from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Galderma Laboratories, L.P. paid the most, $130.

Dmand AI lists 2 awards for Dr. Chon, most recently America’s Best Dermatologists in 2023.

Dr. Chon graduated from Stanford University School Of Medicine in 1997. Dr. Chon is a member of AAD.

Dr. Chon is in network with 22 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.